MichaelAnthonyMcDevittMD

Assistant Professor of Medicine, Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Dr. McDevitt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1992 - 1995
Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1992
Weill Cornell MedicineClass of 1989

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

170 citations
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
Christine L. O'Keefe, Michael A. McDevitt, Jaroslaw P. Maciejewski
Blood. 2010-04-08
54 citations
The Myc Target Gene JPO1/CDCA7 Is Frequently Overexpressed in Human Tumors and Has Limited Transforming Activity In vivo
Rebecca C. Osthus, Baktiar O. Karim, Julia E. Prescott, B. Douglas Smith, Michael A. McDevitt
Cancer Research. 2005-07-01
68 citations
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
Judith E. Karp, B. Douglas Smith, Linda S. Resar, Jacqueline Greer, Amanda L. Blackford
Blood. 2011-03-24

Idaho Pharmacies Prepare for Ages 16+ to Become Eligible for COVID-19 VaccineMarch 26th, 2021
Memorial Medical Center, a State Highly Infectious Disease Facility, Confident in Its Coronavirus PreparednessMarch 12th, 2020